Rankings
▼
Calendar
LUNG Q3 2023 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena
LUNG
Pulmonx Corporation
$75M
Q3 2023 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$18M
+30.9% YoY
Gross Profit
$13M
73.7% margin
Operating Income
-$15M
-85.9% margin
Net Income
-$15M
-84.3% margin
EPS (Diluted)
$-0.39
QoQ Revenue Growth
+2.8%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$185M
Total Liabilities
$59M
Stockholders' Equity
$126M
Cash & Equivalents
$95M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$18M
$14M
+30.9%
Gross Profit
$13M
$10M
+28.3%
Operating Income
-$15M
-$14M
-8.9%
Net Income
-$15M
-$14M
-5.1%
Geographic Segments
UNITED STATES
$12M
67%
EMEA
$5M
27%
Asia Pacific
$814,000
5%
Other International Geographical Areas
$164,000
1%
← FY 2023
All Quarters
Q4 2023 →